Several reports have shown that BCL11A is oncogenic in B‐cell lymphoma, B‐cell chronic lymphoblastic leukemia, and several solid tumors (Satterwhite et al., 2001; Yu et al., 2012; Khaled et al., 2015; Zhang et al., 2016; Xutao et al., 2018; Lazarus et al., 2018). The gene discussed is BCL11A; the disease is B-cell non-Hodgkin lymphoma.